Concierge Telemedicine: Case Studies in Challenging Delivery modelVSee
Session: Physician Entrepreneurs
Speaker: Ravi Kamepalli (Regional infectious diseases and infusion center, Inc.)
Telehealth Secrets Conference 2018 by VSee
More info here: vsee.com/conference
A mobile health application called "CareGoggles" for locating affordable healthcare options for the rehabilitation population in Newark. CareGoggles will improve primary care access and health outcomes, thereby empowering patients to become better stewards of their own health.
Concierge Telemedicine: Case Studies in Challenging Delivery modelVSee
Session: Physician Entrepreneurs
Speaker: Ravi Kamepalli (Regional infectious diseases and infusion center, Inc.)
Telehealth Secrets Conference 2018 by VSee
More info here: vsee.com/conference
A mobile health application called "CareGoggles" for locating affordable healthcare options for the rehabilitation population in Newark. CareGoggles will improve primary care access and health outcomes, thereby empowering patients to become better stewards of their own health.
Tom Deblanco: maximising patient engagementNuffield Trust
Tom Delbanco, MD, MACP and Koplow–Tullis, Professor of Medicine, Harvard Medical School present on maximising patient engagement through health information technology.
Health Literacy Through Testing aims to improve health literacy and the patient-doctor relationship through testing of health literacy in the waiting room. The test will provide a snapshot of a patient's problem areas to improve education and compliance, as well as provide invaluable data regarding health literacy.
Systematic Use of STroke Averting INterventions (SUSTAIN) TrialUCLA CTSI
This study, which is also funded by the American Heart Association, will assess whether lifestyle group clinics, care managers and support from community health workers may reduce the risk of a second stroke in socioeconomically disadvantaged minority patients.
Soraya Ghebleh - Unwarranted Variation in HealthcareSoraya Ghebleh
This is a short paper by Soraya Ghebleh that discusses the causes of unwarranted variation in healthcare delivery and potential strategies to reduce these unwarranted variations.
Copernicus, Copernicus incentivizes diabetic patients in under-served populations to actively engage in their diabetes management through an mobile platform that provides notification, media content and reward incentives for disease tracking, medication adherence, improved health literacy and communication with providers. Users receive points by employing clinically proven health-promoting habits, which can be verified by their health care provider, which can be cashed out for gift cards.
Patients and their loved ones often hold critical knowledge that informs diagnosis. This toolkit from the Institute of Medicine offers patients, families and clinicians guidance on how they can collaborate to improve diagnosis.
Krames Patient Education is the only choice for enterprise-wide patient education. In this presentation, practices will learn who Krames Patient Education is and What we can do for you.
We will review Patient-Centered Care and Patient Education; The Case for a Patient Education Investment, The Krames Differencet; Return on Investment; and Krames Solutions.
April 18, 2018
Decision aids can be highly-effective tools to promote shared decision making and support patients in becoming engaged participants in their healthcare. Join us for the first-ever convening with leaders behind a Washington experiment in certifying decision aids, as state officials, health systems, and on-the-ground implementation experts share lessons learned and discuss policy recommendations for national or statewide approaches to decision aid certification.
For more information, visit our website at: http://petrieflom.law.harvard.edu/events/details/decision-aids-for-patients-with-serious-illness
On 12th December 2013, Dr Hannan (GP / family physician) along with Marilyn Gollom (patient) presented this talk to Health 2.0 Manchester. You can watch the talk by going to http://www.htmc.co.uk/pages/pv.asp?p=htmc0519.
Tom Deblanco: maximising patient engagementNuffield Trust
Tom Delbanco, MD, MACP and Koplow–Tullis, Professor of Medicine, Harvard Medical School present on maximising patient engagement through health information technology.
Health Literacy Through Testing aims to improve health literacy and the patient-doctor relationship through testing of health literacy in the waiting room. The test will provide a snapshot of a patient's problem areas to improve education and compliance, as well as provide invaluable data regarding health literacy.
Systematic Use of STroke Averting INterventions (SUSTAIN) TrialUCLA CTSI
This study, which is also funded by the American Heart Association, will assess whether lifestyle group clinics, care managers and support from community health workers may reduce the risk of a second stroke in socioeconomically disadvantaged minority patients.
Soraya Ghebleh - Unwarranted Variation in HealthcareSoraya Ghebleh
This is a short paper by Soraya Ghebleh that discusses the causes of unwarranted variation in healthcare delivery and potential strategies to reduce these unwarranted variations.
Copernicus, Copernicus incentivizes diabetic patients in under-served populations to actively engage in their diabetes management through an mobile platform that provides notification, media content and reward incentives for disease tracking, medication adherence, improved health literacy and communication with providers. Users receive points by employing clinically proven health-promoting habits, which can be verified by their health care provider, which can be cashed out for gift cards.
Patients and their loved ones often hold critical knowledge that informs diagnosis. This toolkit from the Institute of Medicine offers patients, families and clinicians guidance on how they can collaborate to improve diagnosis.
Krames Patient Education is the only choice for enterprise-wide patient education. In this presentation, practices will learn who Krames Patient Education is and What we can do for you.
We will review Patient-Centered Care and Patient Education; The Case for a Patient Education Investment, The Krames Differencet; Return on Investment; and Krames Solutions.
April 18, 2018
Decision aids can be highly-effective tools to promote shared decision making and support patients in becoming engaged participants in their healthcare. Join us for the first-ever convening with leaders behind a Washington experiment in certifying decision aids, as state officials, health systems, and on-the-ground implementation experts share lessons learned and discuss policy recommendations for national or statewide approaches to decision aid certification.
For more information, visit our website at: http://petrieflom.law.harvard.edu/events/details/decision-aids-for-patients-with-serious-illness
On 12th December 2013, Dr Hannan (GP / family physician) along with Marilyn Gollom (patient) presented this talk to Health 2.0 Manchester. You can watch the talk by going to http://www.htmc.co.uk/pages/pv.asp?p=htmc0519.
Don’t miss our upcoming webinars: Subscribe today!
The CanRehab Team brings together a large group of patients, researchers, and clinicians at four Canadian centres and includes three concurrent projects focused on improving access to effective, appropriate, and timely cancer rehabilitation (CanRehab Team).
The objectives of the presentation are: 1) to provide a background on cancer rehabilitation; 2) to introduce the CanRehab Team projects; and 3) to provide an overview of the team structure including a call for interest to the Patient Advisory Committee.
View the YouTube video: https://youtu.be/B2tcIsrw4WE
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
How to have quality of life in Advanced ovarian malignancyRajesh Gajbhiye
Presentation given by Dr Rakhi Gajbhiye, Mauli Hospital Nagpur at MGIMS sewagram for an International conference on Womens Health Fatal Disorders Survival with Quality in collaboration with FOGSI.
This was the function to commemorate 100 th birth centenary of Dr Sushila
Don’t miss our upcoming webinars. Subscribe today!
About this webinar:The importance of Cancer Rehabilitation The diagnosis and treatment of cancer can result in chronic side effects which interfere with a person’s ability to work, engage socially, and do daily activities. Awareness and understanding of cancer rehabilitation have increased greatly over the past decade. However, access to rehabilitation services remains limited across Canada. There is an urgent call to action to invest in systems and services that can promote the recovery and well-being of cancer survivors. This includes the early identification of physical side effects and the development of effective cancer rehabilitation treatments that can be supported and maintained by our health care system.About This Presenter:Jennifer M. Jones, PhDDr. Jennifer Jones is the Butterfield Drew Chair in Cancer Survivorship Research and the Director of the Cancer Rehabilitation and Survivorship Program at the Princess Margaret Cancer Centre. In addition, she is a Senior Scientist at the Princess Margaret Research Institute and an Associate Professor in the Department of Psychiatry (primary) and the Dalla Lana School of Public Health (cross-appointment) at University of Toronto.Dr. Jones’ most recent scholarly and professional activities have clustered around Translational research to inform clinical survivorship care. This clinical research platform specifically focuses on examining new approaches to predict, prevent and manage long-term adverse effects of cancer and its treatment and evaluating innovative models of follow-up care and support for the growing number of cancer survivors.
View the Video: https://bit.ly/importanceofcancerrehabyoutube
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Multidisciplinary Approach to Prostate Cancer and Changes in Treatment Decisi...CrimsonpublishersCancer
In order to demonstrate the impact of multi-disciplinary care in the community oncology setting, we evaluated treatment decisions following the initiation of a dedicated genitourinary multi-disciplinary clinic (GUMDC).
Only a small percentage of cancer patients are good candidates for proton therapy. Yet, for the right patients, proton therapy can reduce radiation exposure to healthy tissue. To help you make the best care decisions, this slide deck offers information to help you identify those of cancer patients best treated with proton therapy.
C L I N I C A L S T U D YValidation of the Mishel’s uncert.docxhumphrieskalyn
C L I N I C A L S T U D Y
Validation of the Mishel’s uncertainty in illness
scale-brain tumor form (MUIS-BT)
Lin Lin • Alvina A. Acquaye • Elizabeth Vera-Bolanos •
Jennifer E. Cahill • Mark R. Gilbert •
Terri S. Armstrong
Received: 4 May 2012 / Accepted: 3 September 2012 / Published online: 11 September 2012
� Springer Science+Business Media, LLC. 2012
Abstract The Mishel uncertainty in illness scale (MUIS)
has been used extensively with other solid tumors throughout
the continuum of illness. Interventions to manage uncer-
tainty have been shown to improve mood and symptoms.
Patients with primary brain tumors (PBT) face uncertainty
related to diagnosis, prognosis, symptoms and response.
Modifying the MUIS to depict uncertainty in PBT patients
will help define this issue and allow for interventions to
improve quality of life. Initially, 15 experts reviewed the
content validity of the MUIS-brain tumor form (MUIS-BT).
Patients diagnosed with PBT then participated in the study to
test validity and reliability. Data was collected at one point in
time. Six out of 33 items in the original MUIS were modified
to better describe PBT patients’ uncertainty. 32 of the 186
patients in the second-stage of the study were newly diag-
nosed with PBT, 85 were on treatment, and 69 were fol-
lowed-up without active treatment. The validity of the
MUIS-BT was demonstrated by its correlations with mood
states (P \ 0.01) and symptom severity (P \ 0.01) and
interference (P \ 0.01). The MUIS-BT measures four con-
structs: ambiguity/inconsistency, unpredictability of disease
prognosis, unpredictability of symptoms and other triggers,
and complexity. Cronbach’s alphas of the four subscales
were 0.90, 0.77, 0.75 and 0.65, respectively. The 33-item
MUIS-BT demonstrated adequate select measures of valid-
ity and reliability in PBT patients. Based on this initial val-
idation and significant correlations with symptom distress
and mood states, further understanding of uncertainty and
evaluation of measures to help manage patients’ uncertainty
can be evaluated which in turn may improve coping and
quality of life.
Keywords Brain tumors � Quality of life �
Self-report instruments � Symptoms � Uncertainty
Introduction
Primary brain tumors (PBTs) such as gliomas are a heter-
ogenous group of neoplasms associated with significant
morbidity and mortality. Glioblastoma multiforme (GBM)
is the most common and aggressive malignant glioma, and
treatment includes surgical resection, combined radiation
and temozolomide chemotherapy and then with monthly
cycles of temozolomide for up to one year [1, 2]. Once
initial treatment is completed, patients then undergo peri-
odic clinical follow-up with MRI to evaluate disease status.
At the time of recurrence, repeat tumor resection or che-
motherapy may be prescribed. Typically for recurrent
tumors, treatment is continued again until tumor progresses
or clinical symptoms mandate a change in thera ...
Survivorship Care and Care Plans: Transforming Challenges into OpportunitiesCarevive
Dr. Carrie Stricker attended last month's Arizona Cancer Survivorship Care Plan Summit in Phoenix Arizona. The summit was a joint effort between the Arizona Cancer Coalition , the Arizona Department of Health Services, and the Susan G. Komen® Central and Northern Arizona.
Comprehensive Cancer Control (CCC) Programs work in their community to promote healthy lifestyles and recommended cancer screening, educate people about cancer symptoms, increase access to quality cancer care, and enhance cancer survivors' quality of care. The Arizona Department of Health Services developed the Arizona Cancer Coalition for dedicated individuals, professionals, and cancer survivors to address the priorities outlined in the Arizona Cancer Control Plan. These priorities include prevent cancer, detect cancer early, elevate cancer treatment, galvanize quality of life/survivorship care networks, and catalyze research.
Susan G. Kamen® Central and Northern Arizona is one of 120 Affiliates around the world dedicated to combating breast cancer at every front. Its service area encompasses all of central and northern Arizona, including Apache, Coconino, Gila, La Paz, Maricopa, Mohave, Navajo, Pinal and Yavapai counties. Through events like the Susan G. Kamen Phoenix Race for the Cure®, the Affiliate has invested more than $26.4 million in local breast health and breast cancer awareness projects in central and northern Arizona, and breast cancer research.
This summit served as a forum for clinicians, nurses, program planners, and public health professionals within Commission on Cancer (CoC) accredited hospitals to learn about survivorship care plans and address the implementation of standard 3.3 of CoC accreditation.
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Le...Carevive
The 18th CNSA Annual Winter Congress, held Perth, Australia will featured On Q Health’s co-founder Dr. Carrie Stricker as a keynote speaker. The theme for this year’s edition is “Cancer Nursing: Expanding the Possibilities” and will focus on exploring the opportunities that exist in cancer nursing in 2015 and beyond.
Developing a cancer survivorship research agenda - Prof Patricia GanzIrish Cancer Society
A presentation given at the Irish Cancer Society's Survivorship Research Day at the Aviva Stadium, Dublin on Thursday, September 20th, 2013.
Developing a cancer survivorship research agenda: challenges & opportunities - Prof Patricia Ganz, UCLA Fielding School of Public Health
Similar to CHCF Decision Aid Upgrade Informational Webinar (20)
The Catalyst @ Health 2.0/Wipfli Survey on the State of Digital Health 2021 -...health2dev
The final results are in! Take a look now to see the output of the analysis on the Catalyst @ Health 2.0/Wipfli Survey on the State of Digital Health - 2021!
The 2018 AMR API study from Health 2.0. A survey of the experience of the small health tech application companies working with the large EMR vendors. This is an update and expansion of a similar 2016 study. Both studies supported by the California Health Care Foundation.
Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
With support from California Health Care Foundation, earlier this year (2016) Health 2.0 surveyed over 100 small health tech companies to ask their experiences integrating with specific EMR vendors.
Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
FoodCare helps food and beverage businesses understand and meet the needs of millions of individuals and families by providing nutrition-related apps and services.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
the IUA Administrative Board and General Assembly meeting
CHCF Decision Aid Upgrade Informational Webinar
1. Thomas J Smith, MD, Johns
Hopkins Hospital
Decision Aid
Upgrade: A Design
Challenge
2. 2
The Problem
• Current communication between oncologists and their
patients is not satisfactory.
– Only 17% of incurable lung cancer patients could guess that their
prognosis was less than 2 years. 1
– Most (69%) of patients with metastatic lung cancer did not
understand that chemotherapy was very unlikely to cure their
cancer. 2
– 80% of patients want to know the full truth about their diagnosis,
even though it may be uncomfortable or unpleasant.3
1. Liu PH, Landrum MB, Weeks JC, et al. Physicians' propensity to discuss prognosis is associated
with patients' awareness of prognosis for metastatic cancers. Journal of palliative medicine. Jun
2014;17(6):673-682.
2. Weeks JC, Catalano PJ, Cronin A, et al. Patients’ expectations about effects of chemotherapy
for advanced cancer. N Engl J Med. 2012;367(17):1616-1625.
3. IOM (Institute of Medicine). 2013. Delivering high-quality cancer care: Charting a new course
for a system in crisis. Washington, DC: The National Academies Press.
3. 3
The Alternative
• Benefits experienced by people who understand the
trajectory of their illness and their likelihood of survival
– Early and adequate treatment of stress and
symptoms
• Through enrollment in palliative care and/or hospice
– Less depression and anxiety
– Time to clarify end-of-life wishes
– Time for life closure tasks
5. 5
Shouldn’t people get this
information from ___________?
• Yes, but doctors reluctant to share prognostic
information (uncomfortable, hard to do, takes time,
misconceptions about what people actually want.)1
• The Internet does not give people any reasonable
answers, yet.2
– Only 8% of websites addressing the most common 10 cancers had ANY
information about how long the average person would live.
– Or about how effective chemo was at reducing symptoms.
1. Mack JW, Smith TJ. Reasons why physicians do not have discussions about poor
prognosis, why it matters, and what can be improved. J Clin Oncol. 2012 Aug
1;30(22):2715-7.
2. Chik T, Smith TJ. Getting Helpful Information from the Internet about the Prognosis
with Advanced Cancer. J Oncol Prac, in press.
6. 6
The Decision Aid
• Addresses decision points patients face when
considering distinct lines of chemotherapy
• Includes statistical information on:
– The average patient's chances of being alive at one year using a
specific chemotherapy;
– How long it will take for the cancer to begin to grow again after
chemotherapy;
– The likelihood of particular side effects
• Also addresses spiritual, financial issues, and advance
care planning
9. 9
Palliative care
Early palliative care improves quality of life and survival1
RCT of 151 patients with non-small cell lung cancer; 107 (86%)
completed assessments.
Patients had a better quality of life and fewer depressive symptoms
Median survival was 2.7 months longer
Patients were less likely to receive chemotherapy in the
last 60 days of life.2
• Longer interval between last dose of chemotherapy and death
• Higher enrollment in hospice care for longer than 1 week
1. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-
small-cell lung cancer. N Engl J Med. 2010;363(8):733-742.
2. Greer JA, Pirl WF, Jackson VA, et al. Effect of early palliative care on chemotherapy use and
end-of-life care in patients with metastatic non-small-cell lung cancer. J Clinical Oncology.
2012;30(4):394-400.
10. 10
Since 2012 ASCO has recommended
that patients with metastatic or advanced
cancer be offered palliative care,
concurrent with standard treatment
Guidelines / Recommendations
For Oncologists – Professional guidance
For Consumers – Choosing Widely
Patients with cancer that cannot be cured
should talk with their doctors and learn
more about palliative and hospice care
while they are still relatively well.
11. 11
Definitions
• Prognosis: the likely outcome or course of a disease; the
chance of recovery or recurrence
• First Line: the first treatment given for a disease
• Second Line: treatment that is given when initial treatment
(first-line therapy) doesn’t work, or stops working
• Third Line: treatment that is given when both initial
treatment (first-line) and subsequent treatment (second-
line) don’t work, or stop working
• Metastatic disease / Metastasis: when the cancer has
spread from the primary site (place where it started) to
other places in the body
12. 12
Definitions Cont’d
• Palliative radiation: radiation to alleviate pain, remove
compression of tumor on a vital organ, or prevent fracture if
the cancer has spread to a weigh-bearing bone
• Palliative Care: care given to improve the quality of life of
patients who have a serious or life-threatening disease. The
goal of palliative care is to prevent or treat as early as
possible the symptoms of a disease, side effects caused by
treatment of a disease, and psychological, social, and
spiritual problems related to a disease or its treatment.
Palliative care is appropriate at any stage of a serious illness.
• Hospice: a program that provides special care for people
who are near the end of life and for their families, either at
home, in freestanding facilities, or within hospitals